Bradycardia: Difference between revisions

Jump to navigation Jump to search
2,568 bytes added ,  7 January 2014
no edit summary
No edit summary
No edit summary
Line 76: Line 76:
Paroxysmal atrioventricular block (PAVB), is characterized by a sudden and unexpected block of the atrial impulse. Due to the delayed emerge of an escape rhythm, these patients often present with syncope. However, if a escape rhythm is established patients may present themselves without symptoms. Two different variations of the PAVB are commonly distinguished;
Paroxysmal atrioventricular block (PAVB), is characterized by a sudden and unexpected block of the atrial impulse. Due to the delayed emerge of an escape rhythm, these patients often present with syncope. However, if a escape rhythm is established patients may present themselves without symptoms. Two different variations of the PAVB are commonly distinguished;


<b>1. Pause-dependent PAVB</b>
The PD-PAVB occurs after the onset of a pause. This pause can be compensatory after a premature beat, overdrive suppression of sinus rhythm or other disorders of impulse formation. There are several hypothesis to explain this phenomenon, amongst them phase 4 depolarization (see Phase 4 abberation).
<b>2. Tachycardia-dependent PAVB</b>
The TD-PAVB occurs more frequently in patients due to the increased rate of the atria. TD-PAVB is associated with 2nd degree Mobitz block and Adam-Stokes Syndrome. However, some occurrences of TD-PAVB occur without a noticeable increase in atrial rate, due to minor electrophysiological changes due to changes in autonomic tone or coronary perfusion. The mechanism responsibly for the occurrence of TD-PAVB is probably repetitive concealed conduction.<cite>Elsherrif</cite>




==Ventricular Conduction Block==
==Ventricular Conduction Block==
Ventricular conduction blocks predominantly prolong the QRS-complex, but are rarely the result of bradycardias. However, the occurrence of ventricular block on the surface ECG inform the clinician about the health of the underlying conduction system and might occur simultaneously with other types of conduction disorders. 


===Right bundel branch block (RBBB)===
===Right bundel branch block (RBBB)===
The right bundle branch is composed of one fascicle. Right bundle branch block is a unifascicular block of the right bundle and can be found in healthy people and is represented by a broad QRS complex (>120ms). However a new RBBB in a patient with a history of normal ventricular conduction warrens further cardiological investigation. The last activity is to the right and results in a RSR’ pattern in V1 where R’ > R. This results from the delayed activation of the right ventricle. In V6 a slurred S wave can be seen at the end of the QRS complex.
The right bundle branch is composed of one fascicle. Right bundle branch block is a unifascicular block of the right bundle and can be found in healthy people and is represented by a broad QRS complex (>120ms). However, a new RBBB in a patient with a history of normal ventricular conduction warrens further cardiological investigation. The last activity is to the right and results in a RSR’ pattern in V1 where R’ > R. This results from the delayed activation of the right ventricle. In V6 a slurred S wave can be seen at the end of the QRS complex<cite>ESC, ECGpedia, Robles, Wellens</Cite>


===Left anterior fascicular block (LAFB)===
===Left anterior fascicular block (LAFB)===
The left bundle branch is composed of two fascicles. One of the fascicle has an anterior location and activates the interventricular septum and the anterior of the ventricle. Clinically this is represented by a left axis deviation and an absent or very small S and normal q in lead I and a S>R in lead II and III. QRS duration should be <120ms.
The left bundle branch is composed of two fascicles. One of the fascicle has an anterior location and activates the interventricular septum and the anterior of the ventricle. Clinically a LAFB is represented by a left axis deviation and an absent or very small S and normal q in lead I and a S>R in lead II and III. QRS duration should be <120ms<cite>ESC, ECGpedia, Robles, Wellens</Cite>.


===Left posterior fascicular block (LPFB)===
===Left posterior fascicular block (LPFB)===
The second fascicle of the left bundle branch is the posterior fascicle. This fascicle has a posterior location and activates the posterior and lateral part of the ventricle. This fascicular block results in a right axis deviation and is represented by a deep S in I and small q in III with a QRS duration of <120ms.
The second fascicle of the left bundle branch is the posterior fascicle. This fascicle has a posterior location and activates the posterior and lateral part of the ventricle. A left posterior fascicular block results in a right axis deviation and is represented by a deep S in I and small q in III with a QRS duration of <120ms<cite>ESC, ECGpedia, Robles,Wellens</Cite>.


===Left bundel branch block (LBBB)===
===Left bundel branch block (LBBB)===
If the two fascicles of the left bundle branch show conduction block there is a left bundle branch block, this bifascicular block is uncommon in healthy patients and further cardiologic investigations need to be performed to screen for underlying disease. Left bundle branch block causes the left ventricle to activate later then the right ventricle. This results in typical ECG characteristics, most importantly a broad QRS of >120ms. In V1 a broad monomorphic S wave can be seen (sometimes with a small r wave) representing slow left ventricular activation. In the lead V6 a broad monomorphic R wave is seen with no Q waves.
If the two fascicles of the left bundle branch show conduction block there is a left bundle branch block. This bifascicular block is uncommon in healthy patients and further cardiologic investigations need to be performed to screen for underlying disease. Left bundle branch block causes the left ventricle to activate later then the right ventricle. This results in typical ECG characteristics, most importantly a broad QRS of >120ms. In V1 a broad monomorphic S wave can be seen (sometimes with a small r wave) representing slow left ventricular activation. In the lead V6 a broad monomorphic R wave is seen with no Q waves<cite>ESC, ECGpedia, Robles, Wellens</Cite>.  
[Afbeelding samenvatting alle Ventriculaire geleidingsstoornissen]


[[File:Intraventricular Conduction.svg|thumb|600px|Traces of right bundle branch block and the different types of left bundle branch conduction disorders.]]
[[File:Intraventricular Conduction.svg|thumb|600px|Traces of right bundle branch block and the different types of left bundle branch conduction disorders.]]


==Functional conduction disorders: Aberrant Conduction==
==Functional conduction disorders: Aberrant Conduction==
In certain conditions a conduction disorder can arise on the ECG. This functional conduction disorder is called aberrant conduction and can mimic any form of interventricular conduction disorder. In most cases a right bundle branch block pattern can be seen on the surface ECG because the right bundle has a longer refractory period. There are a few mechanisms which can cause aberrant conduction.
In certain physiological conditions a ventricular conduction disorder can arise on the ECG. This functional conduction disorder is called aberrant conduction and can mimic any form of interventricular conduction disorder. In most cases a right bundle branch block pattern can be seen on the surface ECG because the right bundle has a longer refractory period. There are a few mechanisms which can cause aberrant conduction<cite>Robles, Wellens</Cite>.
===Phase 3 aberration===
===Phase 3 aberration===
Phase 3 aberration is a situation that occurs when the bundle branches receive a new impulse, before they are repolarized. The bundles are still in their refractory period. This is also called Ashman phenomenon. As a result of the refractionary state of the bundle, conduction can not proceed along the refractory bundle and a conduction block is visible on the surface ECG. Thus for instance short coupled atrial activity can procedure phase 3 abberant conduction.
Phase 3 aberration is a situation that occurs when the bundle branches receive a new impulse, before they are repolarized. The bundles are still in their refractory period. This is also called Ashman phenomenon. As a result of the refractionary state of the bundle, conduction can not proceed along the refractory bundle and a conduction block is visible on the surface ECG. Thus for instance short coupled atrial activity can procedure phase 3 aberrant conduction<cite>Robles, Wellens</Cite>.
===Phase 4 abberation or deceleration dependant===
===Phase 4 abberation or deceleration dependant===
During a prolonged interval the Purkinje fibers can depolarize spontaneously. This depolarisation results in the conduction slowing and can even produce a conduction block. This is usually a pathological response, resulting from an increased activity in the Purkinje fibers, but can be normal at very low heart rates. Phase 4 aberration thus only occurs after prolonged pause.
During a prolonged interval between cardiac activity, the Purkinje fibers can depolarize spontaneously. This depolarisation results in the conduction slowing and can even produce a conduction block. This is usually a pathological response, resulting from an increased activity in the Purkinje fibers, but can be normal at very low heart rates. Phase 4 aberration thus only occurs after prolonged pause <cite>Robles, Wellens</Cite>.  
===Acceleration dependant===
===Acceleration dependant===
This kind of aberrant conduction resembles phase 3 aberrant conduction; however appearance of the conduction disorders is the result of a small increase in rhythm. The conduction disorder is a result of an abnormal response of tissue that has diminished excitability.
This kind of aberrant conduction resembles phase 3 aberrant conduction; however appearance of the conduction disorders is the result of a small increase in rhythm. The ventricular conduction disorder is a result of an abnormal response of tissue that has diminished excitability and fails to excite the corresponding bundle<cite>Robles, Wellens</Cite>.
 
=Diagnosis=
=Diagnosis=
In the diagnosis of bradyarrhythmias the identification of reversible causes is important to prevent unnecessary treatment. After a detailed history and physical examination there are additional investigations which can give information about the location of the nature of the bradyarrhythmia. While not all investigations are necessary, a thorough work-up has to be performed to prevent serious clinical events or pacemaker implantation. Espaccially the differentiation between bradyarrhtyhmias and vasovagal syncope can be difficult, but is very important for the management of symptoms.
In the diagnosis of bradyarrhythmias the identification of reversible causes is important to prevent unnecessary treatment. After a detailed history and physical examination there are additional investigations which can give information about the location of the nature of the bradyarrhythmia.<cite>Mangrum</cite>. While not all investigations are necessary, a thorough work-up has to be performed to prevent serious clinical events or pacemaker implantation. Especially the differentiation between bradyarrhtyhmias and vasovagal syncope can be difficult, but is very important for the management of symptoms <cite>Mova</cite>.
===Symptoms===
===Signs & Symptoms===
A patient with a bradyarrhythmia can be complete asymptomatic. However patients with bradycardia may present with a diversity of signs and symptoms. A complete cardiac standstill can result in syncope (pause >6 sec) or near syncope. More often symptoms are nonspecific and chronic and are a result of the chronotopic incompetence and reduced cardiac output. Symptoms like for example, dizziness, light-headedness or confusional states, episodes of fatigue or muscular weakness, exercise intolerance, heart failure or palpitations can be described by the patient.
A patient with a bradyarrhythmia can be completely asymptomatic. Otherwise, patients with bradycardia may present with a diversity of signs and symptoms. A pause in ventricular contraction > 6 seconds often resuls in syncope or near syncope <cite>Mova</cite>. More often symptoms are nonspecific and chronic and are a result of the chronotopic incompetence and reduced cardiac output. Symptoms like dizziness, light-headedness or confusional states, episodes of fatigue or muscular weakness, exercise intolerance, heart failure or palpitations can be experienced by the patient.<cite>ESC</cite>
===Investigations===
===Investigations===
There are a number of additional investigations which can uncover the cause of bradyarrhythmias.
There are a number of additional investigations which can uncover the cause of bradyarrhythmias.
* <b>ECG:</b> A surface ECG can demonstrate the conduction disorder and relate complaints to electrocardiographic findings. A Valsalva manoeuvre or carotid sinus massage whilst performing an ECG can give information about function of the autonomous nervous system and its possible role in the occurrence of the bradyarrrhythmia.
* <b>ECG:</b> A surface ECG can demonstrate the conduction disorder and relate complaints to electrocardiographic findings. A Valsalva manoeuvre or carotid sinus massage whilst performing an ECG can give information about function of the autonomous nervous system and its possible role in the occurrence of the bradyarrrhythmia.
* <b>X-ECG:</b> An exercise test can give information about the chronotropic competence of the cardiac conduction system.
* <b>X-ECG:</b> An exercise test can give information about the chronotropic competence of the cardiac conduction system <cite>Wiens</cite>.
* <b>Long-term ECG recording:</b> Holter recording can identify causes of paroxysmal or intermittent bradyarrhythmias. Importantly a correlation with symptoms can be made and pathological causes of bradyarrhythmias or long pause (>3sec) during the night can be identified. If 24h or 48h Holter recordings cannot identify the cause of symptoms longer duration of monitoring may be required.  Transient event recorders can record up to 30seconds of ECG when a patient activates the device. This device can be especially useful when non-invasive monitoring is required due to the low occurrence of the bradyarrhythmia. For longer monitoring an implantable loop recorder can be used. This small device can be implanted and observe rhythm over an extensive period.  
* <b>Long-term ECG recording:</b> Holter recording can identify causes of paroxysmal or intermittent bradyarrhythmias. Importantly a correlation with symptoms can be made and pathological causes of bradyarrhythmias or long pause (>3sec) during the night can be identified. If 24h or 48h Holter recordings cannot identify the cause of symptoms longer duration of monitoring may be required<cite>Lichstein</cite>.  Transient event recorders can record up to 30seconds of ECG when a patient activates the device. This device can be especially useful when non-invasive monitoring is required due to the low occurrence of the bradyarrhythmia<cite>Kinley</cite>. For longer monitoring an implantable loop recorder can be used. This small device can be implanted and observe rhythm over an extensive period <cite>Krahn</cite>.
* <b>Electrophysiological testing:</b> If non-invasive testing does not discover the bradyarrhythmia underlying the symptoms and electrophysiologic study may be undertaken to assess sinus nodal function and atrioventricular conduction. The measurement of conduction intervals and reaction to standard electrophysiological pacing protocols can elucidate the cause of bradyarrhtyhmia.
* <b>Electrophysiological testing:</b> If non-invasive testing does not discover the arrhythmia underlying the symptoms, an electrophysiologic study may be undertaken to assess sinus nodal function and atrioventricular conduction. The measurement of conduction intervals and reaction to standard electrophysiological pacing protocols can elucidate the cause of bradyarrhtyhmia.


=Treatment=
=Treatment=
Fortunately the human heart has a couple of backup mechanisms that can sustain a heart rate in case of severe bradycardia. These escape mechanisms can occur in every part of the heart (i.e. atrium, AV, node, ventricle). In general, the rate of the escape mechanism is faster when the escape rhythm is located higher in the conduction system. If no reversible cause for the bradyarrhythmia can be found and the bradyarrhythmia persist, further therapy is required if the patients remains symptomatic.
Fortunately the human heart has a couple of backup mechanisms that can sustain a heart rate in case of severe bradycardia. These escape mechanisms can occur in every part of the heart (i.e. atrium, AV, node, ventricle). In general, the rate of the escape mechanism is faster when the escape rhythm is located higher in the conduction system, for instance an escape rhythm of the atrium has a higher frequency than an escape rhythm from the ventricles. If no reversible cause for the bradyarrhythmia can be found and the bradyarrhythmia persist, further therapy is required if the patients remains symptomatic.
===Drug Therapy===
===Drug Therapy===
There are no options for chronic drug therapy in bradyarrhthmias. In the acute setting atropine or isoprenaline may be used to increase heart rate or AV-nodal conduction. Patients with severe bradyarrhythmias (Type 2 AV nodal Mobitz II block, Type 3 AV nodal block, sinus arrest >3 seconds) should be considered for permanent or temporary pacing therapy.
There are no options for chronic drug therapy in bradyarrhthmias. In the acute setting atropine or isoprenaline may be used to increase heart rate or AV-nodal conduction <cite>Hoffman</cite>. Patients with severe bradyarrhythmias (Type 2 AV nodal Mobitz II block, Type 3 AV nodal block, sinus arrest >3 seconds) should be considered for permanent or temporary pacing therapy.
===Temporary pacing===
===Temporary pacing===
Temporary pacing can be used to bridge the time to pacemaker implantation or until the bradyarrhythmia is resolved. Transvenous pacing is the most accepted method and can be used to pace the right atrium or the right ventricle after insertion of a temporary pacemaker wire through venous access. Pacing through the oesophagus can only capture the atrium, due to the anatomical position of the heart in relation with the oesophagus. Transcutanous pacing is a painful and emergency option in which muscle and heart are stimulated with large electrodes. Finally epicardal pacing is usually performed after cardiac surgery and requires surgical implantation of the electrodes.
Temporary pacing can be used to bridge the time to pacemaker implantation or until the bradyarrhythmia is resolved. Transvenous pacing is the most accepted method and can be used to pace the right atrium or the right ventricle after insertion of a temporary pacemaker wire through venous access. Pacing through the oesophagus can only capture the atrium, due to the anatomical position of the heart in relation with the oesophagus. Transcutanous pacing is a painful and emergency option in which muscle and heart are stimulated with large electrodes. Finally epicardal pacing is usually performed after cardiac surgery and requires surgical implantation of the electrodes on the epicardium.
===Device Therapy===
===Device Therapy===
Implantable pacemakers activate cardiac myocardium with electrical stimulation, leading to muscle contraction. Due to the nature of a pacemaker, the activation is different from the physiological conduction system, there are electrical and mechanical consequences. It is therefore important to adjust pacemaker setting to the individual patient. The type of pacemakers and their settings are extensively covered in the device chapter of cardiac arrhythmias. The indications for pacemaker implantation in patients with bradyarrhythmias are mentioned below.
Implantable pacemakers activate cardiac myocardium with electrical stimulation, leading to muscle contraction. Due to the nature of a pacemaker, the activation is different from the physiological conduction system, there are electrical and mechanical consequences. It is therefore important to adjust pacemaker setting to the individual patient. The type of pacemakers and their settings are extensively covered in the device chapter of cardiac arrhythmias. The indications for pacemaker implantation in patients with bradyarrhythmias are mentioned below.
* <b>Sinus node disease:</b> Pacemaker implantation should be considered in patients with sinus node disease which manifests as symptomatic bradycardia in which the symptom-rhythm correlation must have been 1) spontaneously occurring or 2) drug-induced where alternative drug therapy is lacking. Furthermore other eligible candidates for permanent pacing are patients with syncope with sinus node disease, either spontaneously occurring or induced at electrophysiological study and sinus node disease manifests as symptomatic chronotropic incompetence which is 1) spontaneously occurring or 2) drug-induced where alternative drug therapy. Patients with sinus node disease without symptoms including use of bradycardia-provoking drugs, ECG findings of sinus node dysfunction with symptoms not due directly or indirectly to bradycardia or symptomatic sinus node dysfunction where symptoms can reliably be attributed to non-essential medication do not have an indication for permanent pacemaker therapy.
* <b>Sinus node disease:</b> Pacemaker implantation should be strongly considered in patients with sinus node disease which manifests as symptomatic bradycardia in which the symptom-rhythm correlation must have been 1) spontaneously occurring or 2) drug-induced where alternative drug therapy is lacking.<cite>Kay, Epstein</cite> Other reasonable eligible candidates for permanent pacing are patients with syncope with sinus node disease, spontaneously occurring or induced at electrophysiological study or patients with symptoms clearly associated to bradycardia but without documentation of this bradycardia.
* <b>Atrioventricular Block:</b> The following patients with AV conduction block have an indication for pacemaker therapy; 1) chronic symptomatic third or second degree (Mobitz I or II) atrioventricular block 2) neuromuscular diseases (e.g. myotonic muscular dystrophy etc.) with third-degree or second-degree atrioventricular Block or 3) third or second degree (Mobitz I or II) atrioventricular block after catheter ablation of the atrioventricular junction or after valve surgery when the block is not expected to resolve. Patients with asymptomatic first degree atrioventricular block, asymptomatic second degree Mobitz I with supra-Hisian conduction block or atrioventricular block expected to resolve do not require a pacemaker implantation.
Patients with sinus node disease without symptoms including use of bradycardia-provoking drugs, patients with symptoms of sinus node dysfunction occurring in the absence of the bradycardia or patients with symptomatic sinus node dysfunction where symptoms can reliably be attributed to non-essential medication do not have an indication for permanent pacemaker therapy.<cite>Epstein</cite>
* <b>Intraventricular conduction Block:</b> Patient which show a intermittent third-degree atrioventricular block, second-degree Mobitz II atrioventricular block. alternating bundle branch block or findings on electrophysiological study of markedly prolonged His-Ventrical interval (≥100ms) or pacing-induced infra-His block in patients with symptoms have an indication for pacemaker therapy. Patients with a bundle branch block without atrioventricular block or symptoms and bundle branch block with first-degree atrioventricular block without symptoms should not have a pacemaker implanted.
* <b>Atrioventricular Block:</b> The following patients with AV conduction block have an strong indication for pacemaker therapy; 1) chronic symptomatic third or second degree (Mobitz I or II) atrioventricular block including induced third or second degree atrioventricular block by required medication<cite>Kastor, Dreifus, Epstein</cite> 2) asymptomatic patients with third or second degree (Mobitz I or II) atrioventricular block and documented asystole greater than 3.0 seconds in SR or 5.0 seconds in AF, an escape rhythm less than 40 bpm (or >40 bpm with left ventricular dysfunction) or infranodal escape rhythm <cite>Epstein, Ecktor, Shaw</cite>3) neuromuscular diseases (e.g. myotonic muscular dystrophy, Kearns–Sayre syndrome, etc.) with third-degree or second-degree atrioventricular Block<cite>Stevenson, James</cite> or 4) third or second degree (Mobitz I or II) atrioventricular block after catheter ablation of the atrioventricular junction or after valve surgery when the block is not expected to resolve<cite>Langberg, Kim, Glikson, Epstein</cite> and 5) patient with third or second degree AV block during exercise with no myocardial ischemia<cite>Chokski, Epstein</cite>. Patients with asymptomatic first degree atrioventricular block, asymptomatic second degree Mobitz I with supra-Hisian conduction block or atrioventricular block expected to resolve do not require a pacemaker implantation.<cite>Mymin, Strasberg, Epstein</cite>
* <b>Intraventricular conduction Block:</b> Patient which show a intermittent third-degree atrioventricular block, advanced second-degree or Mobitz II atrioventricular block have an strong indication for pacemaker therapy<cite>Dhingra, McAnulty1, McAnulty2, Friedberg, Epstein</cite>. Patients with a bundle branch block without atrioventricular block or symptoms and bundle branch block with first-degree atrioventricular block without symptoms should not have a pacemaker implanted.<cite>McAnulty, Epstein</cite>


=References=
=References=

Navigation menu